The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
MedPlus Health Services Limited is an India-based company. The Company is primarily engaged in retail trading of medicines and general items, wholesale cash and carry and pathological laboratory testing services, wholesale trading and manufacturing of pharmaceutical products,…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A decent, fast-growing business, trading cheap versus its own history.
Medplus Health is scored on the pharma / healthcare framework. It keeps a thin 3.1% of every rupee of sales as net profit. Those profits are backed by real cash — operating cash flow runs 2.46× reported profit. Free cash flow is worth about 3.1% of its market value.
Over the last 3 years revenue compounded at 15%/yr and profit at 64%/yr. Book value has grown 10%/yr. Return on equity is a modest 10.2%. In the latest quarter profit grew 69% versus the prior quarter.
At 33× earnings, the stock sits at the 2nd percentile of its own 3.6-year range — the cheap end of where it has historically traded. Today's price implies ~16%/yr earnings growth for a decade. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 34.38 | — | — |
| P/B | 3.51 | 4.1 | better |
| EV/EBITDA | 11.95 | 19.33 | better |
| ROE | 10.2 | — | — |
| ROCE | 11.05 | 14.41 | worse |
| ROA | 5.03 | 1.64 | better |
| Quick Ratio | 1 | 4.8 | worse |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Avenue Supermarts | 71.7 | 8.6 | 11.9% |
| Trent | 85.9 | 21.1 | 24.4% |
| Vishal Mega Mart | 49.0 | 5.6 | 11.4% |
Revenue has grown every year across all 4 financial years shown. 15% CAGR over 3 years — steady double-digit compounder.
Net profit has risen every year — the hallmark of a compounder. Profit is growing faster than revenue (64% vs 15%) — margin expansion is at work. The latest year saw a +46% swing — check if it's a one-off or structural.
Operating margin has expanded from 1% to 4% — the business is keeping more of each rupee earned.
ROE at 11% — modest; the capital isn't working hard. Capital efficiency improving — ROE up 8pp across the window.
EPS has grown every year — each share earns more than the last, consistently. 64% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
Operating cash flow has been positive every year — the business generates real cash, not just accounting profit. Cash conversion at 2.5× PAT — earnings are well-backed by cash; strong accrual quality. Financing outflows in consecutive years — balance-sheet discipline through debt repayment or dividends.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue rose 8% sequentially — momentum is building.
Profit jumped 69% QoQ — check if this is operating leverage or a one-off item.
How today's P/E compares to the stock's own historical range. Dashed line = the 3.6y median.
Promoters at 40.2% — dispersed ownership; institutional flows drive the stock. FIIs trimmed 4.2pp — foreign money is rotating out. MF holding up 5.9pp — domestic institutional discovery underway.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.